24 Jul OTTAVA, Johnon & Johnson’s Robotic Entry Gains USFDA Clearance

The U.S. Food and Drug Administration has granted a De Novo approval for Johnson & Johnson (J & J) to market OTTAVA* their long-anticipated entry into the robotic surgery category. The USFDA De Novo approval means that J & J has proven that the...